Decision Driver Analytics Expands Team, Adds Health Economics Expertise
Decision Driver Analytics (DDA), a premier provider of product life cycle value analysis and health economic insight for drug and medical device developers, has announced the appointment of Heather Vecchiolla as vice president of business development and Madeline C. Rhoton as health economist.
“I am delighted to welcome Heather and Madeline to our team,” said Elizabeth Brooks, president and founder of Decision Driver Analytics. “They add experience, expertise and depth to our organization and will enhance our ability to deliver expert strategies and assist our clients in making high-value decisions.”
Vecchiolla has more than a decade of experience building and maintaining valuable business relationships in the drug and medical device development sector. Most recently, she was the senior director of business development at ICON’s Commercialization and Outcomes group, where she concentrated on commercialization strategies throughout the development and launch cycles.
“With the rapid advancements in treatment and diagnostics, this is an exciting time to be in the health care industry,” Vecchiolla said. “As part of the DDA team, I’ll be supporting our clients as they navigate this challenging and evolving landscape.”
Rhoton, a graduate of Duke University’s public policy analysis program, previously held an internship position at DDA, where she gained focused experience in health economics and outcomes research. As a health economist, she will provide medical device firms with practical knowledge so they can leverage their technologies’ value propositions and make informed decisions throughout the development process.
“Madeline became invaluable to our team during her internship,” Brooks said. “We’re excited for her to join our team in her new position and continue to be an asset to our clients with her outstanding research and data analytics skills.”
About Decision Driver Analytics
Founded in 2006, Decision Driver Analytics provides a suite of services that covers the full range of health economics and outcomes research (HEOR) as well as the outreach materials needed to reach investors, health care providers, payers and the public. Utilizing veteran health economists, epidemiologists, biostatisticians, medical writers and reimbursement experts, DDA’s services include complete product life cycle value analysis, strategy and planning, clinical economic study services, predictive modeling analytics, definitive analysis studies, communication and sales training.